Compare RAMP & BCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RAMP | BCRX |
|---|---|---|
| Founded | 2018 | 1986 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 2.1B |
| IPO Year | 1994 | 1995 |
| Metric | RAMP | BCRX |
|---|---|---|
| Price | $29.51 | $8.52 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 5 | 11 |
| Target Price | ★ $35.60 | $20.82 |
| AVG Volume (30 Days) | 916.5K | ★ 4.1M |
| Earning Date | 05-04-2026 | 05-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 381.40 |
| EPS | 1.14 | ★ 1.21 |
| Revenue | ★ $745,580,000.00 | $25,186,000.00 |
| Revenue This Year | $11.15 | N/A |
| Revenue Next Year | $9.10 | $12.55 |
| P/E Ratio | $25.81 | ★ $7.00 |
| Revenue Growth | ★ 13.02 | N/A |
| 52 Week Low | $21.71 | $6.00 |
| 52 Week High | $35.20 | $11.31 |
| Indicator | RAMP | BCRX |
|---|---|---|
| Relative Strength Index (RSI) | 69.90 | 70.29 |
| Support Level | $26.39 | $7.95 |
| Resistance Level | $30.80 | $8.68 |
| Average True Range (ATR) | 1.10 | 0.33 |
| MACD | 0.52 | 0.10 |
| Stochastic Oscillator | 96.69 | 81.22 |
LiveRamp Holdings Inc is a technology company that helps companies build enduring brand and business value by collaborating responsibly with data. A groundbreaking leader in consumer privacy, data ethics, and foundational identity, LiveRamp offers a connected customer view with clarity and context while protecting brand and consumer trust. The Company provides a data collaboration platform, essentially acting as a data collaboration hub where businesses can securely share and manage first-party consumer data with trusted partners while prioritizing data privacy and ethics.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.